1,695
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Overtreatment in end-of-life care: how can we do better?

Pages 1435-1436 | Received 22 Dec 2022, Accepted 31 Dec 2022, Published online: 09 Jan 2023

References

  • Cardona-Morrell M, Kim J, Turner RM, et al. Non-beneficial treatments in hospital at the end of life: a systematic review on extent of the problem. Int J Qual Health Care. 2016;28(4):456–469.
  • Crawford GB, Dzierżanowski T, Hauser K, et al. Care of the adult cancer patient at the end of life: ESMO clinical practice guidelines. ESMO Open. 2021;6(4):100225.
  • Forschner A, Loquai C, Meiss F, et al. Is there an overtreatment of melanoma patients at the end of their life? Results of a multicenter study on 193 melanoma patients. J Dtsch Dermatol Ges. 2021;19(9):1297–1305.
  • McNeil MJ, Kamal AH, Kutner JS, et al. The burden of polypharmacy in patients near the end of life. J Pain Symptom Manage. 2016;51(2):178–183 e2.
  • Clapp JT, Schwarze ML, Fleisher LA. Surgical overtreatment and shared decision-making-the limits of choice. JAMA Surg. 2022;157(1):5–6.
  • Szilcz M, Wastesson JW, Morin L, et al. Potential overtreatment in end-of-life care in adults 65 years or older dying from cancer: applying quality indicators on nationwide registries. Acta Oncol. 2022. DOI:10.1080/0284186X.2022.2153621
  • Cai J, Zhang L, Guerriere D, et al. Congruence between preferred and actual place of death for those in receipt of home-based palliative care. J Palliat Med. 2020;23(11):1460–1467.
  • Costa V, Earle CC, Esplen MJ, et al. The determinants of home and nursing home death: a systematic review and meta-analysis. BMC Palliat Care. 2016;15:8.
  • Gomes B, Calanzani N, Gysels M, et al. Heterogeneity and changes in preferences for dying at home: a systematic review. BMC Palliat Care. 2013;12:7.
  • Rasch-Westin M, Helde-Frankling M, Björkhem-Bergman L. Death at home: predictive factors in a medical home care unit. BMJ Support Palliat Care. 2019:bmjspcare-2019-001932.
  • Hui D, Paiva CE, Del Fabbro EG, et al. Prognostication in advanced cancer: update and directions for future research. Support Care Cancer. 2019;27(6):1973–1984.
  • Ju SY, Ma SJ. High C-reactive protein to albumin ratio and the short-term survival prognosis within 30 days in terminal cancer patients receiving palliative care in a hospital setting: a retrospective analysis. Medicine. 2020;99(9):e19350.
  • Mori M, Morita T, Bruera E, et al. Prognostication of the last days of life. Cancer Res Treat. 2022;54(3):631–643.
  • Seebacher V, Grimm C, Reinthaller A, et al. The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2013;171(1):101–106.
  • Simmons CPL, McMillan DC, McWilliams K, et al. Prognostic tools in patients with advanced cancer: a systematic review. J Pain Symptom Manage. 2017;53(5):962–970 e10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.